Perhaps the strongest evidence for a loss-of-function mechanism is the finding that individuals with biallelic GBA1 mutations have a substantially elevated risk for developing PD relative to heterozygous GBA1 mutation carriers [3, 4, 49]. The gene discussed is GBA1; the disease is Parkinson disease.